INIS
india
100%
patients
97%
hospitals
87%
risks
37%
diseases
37%
control
34%
viruses
33%
detection
31%
antibiotics
30%
surveillance
27%
mortality
26%
genes
26%
reviews
25%
staphylococcus
24%
bacteria
20%
blood
19%
units
19%
communities
19%
pathogens
19%
humans
18%
epidemiology
16%
data
15%
pneumonia
15%
surveys
14%
comparative evaluations
14%
levels
14%
influenza
12%
covid-19
12%
therapy
12%
laboratories
11%
tuberculosis
11%
virulence
10%
evaluation
10%
cost
10%
pcr
10%
abscesses
10%
images
10%
management
9%
sensitivity
9%
assessments
9%
escherichia coli
8%
resources
8%
bacillus
8%
stains
8%
encephalitis
8%
strains
8%
host
7%
transmission
7%
concentration
7%
world health organization
7%
surgery
7%
distribution
7%
dynamics
7%
teaching
7%
variations
7%
morbidity
7%
liver
7%
drugs
6%
fever
6%
optimization
6%
asia
6%
mutations
6%
adults
6%
cerebrospinal fluid
6%
bones
6%
osteomyelitis
6%
kidneys
6%
genetics
6%
solutions
6%
errors
6%
testing
6%
injuries
6%
sensors
6%
hepatitis
6%
values
5%
brucella
5%
vitamin d
5%
amplification
5%
gene mutations
5%
nepal
5%
waste water
5%
infectious diseases
5%
substrates
5%
tissues
5%
environment
5%
correlations
5%
classification
5%
losses
5%
nanoparticles
5%
performance
5%
Medicine and Dentistry
Melioidosis
50%
Infection
22%
Tertiary Care
21%
Disease
14%
Burkholderia pseudomallei
12%
Infection Control
10%
Healthcare Associated Infection
9%
Pathogen
9%
Infection Prevention
9%
Methicillin Resistant Staphylococcus Aureus
9%
Intensive Care Unit
9%
Bloodstream Infection
8%
COVID-19
8%
Abscess
8%
Sepsis
8%
Staphylococcus Aureus
8%
Cohort Effect
6%
Meticillin
6%
Retrospective Cohort Study
6%
Prevalence
6%
Community-Acquired Pneumonia
6%
Awareness
6%
Health Care Cost
6%
Probiotic Agent
5%
Ventilator-Associated Pneumonia
5%
Antibiotics
5%
Health Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
25%
Antiinfective Agent
15%
Antibiotic Resistance
14%
Melioidosis
14%
Antimicrobial Resistance
14%
Prevalence
13%
Staphylococcus Aureus
12%
Antibiotics
12%
Disease
9%
Escherichia coli
8%
Methicillin-Resistant Staphylococcus Aureus
8%
Hospital Infection
6%
Probiotic Agent
6%
Antivirus Agent
6%
Chronic Osteomyelitis
6%
Respiratory Tract Infection
5%
Methicillin Resistant Staphylococcus Aureus Infection
5%
Osteomyelitis
5%
Silver Nanoparticle
5%
Vitamin D
5%
Epidemiology
5%
Cohort Study
5%
Bloodstream Infection
5%
Observational Study
5%